Rosalind and Morris Goodman Cancer Research Center, McGill University, Montreal, Quebec H3A 1A3, Canada.
Department of Medicine, McGill University, Montreal, Quebec H3A 1A3, Canada.
Sci Adv. 2020 Jan 22;6(4):eaax0021. doi: 10.1126/sciadv.aax0021. eCollection 2020 Jan.
Lysine acetyltransferase 6A (KAT6A) and its paralog KAT6B form stoichiometric complexes with bromodomain- and PHD finger-containing protein 1 (BRPF1) for acetylation of histone H3 at lysine 23 (H3K23). We report that these complexes also catalyze H3K23 propionylation in vitro and in vivo. Immunofluorescence microscopy and ATAC-See revealed the association of this modification with active chromatin. deletion obliterates the acylation in mouse embryos and fibroblasts. Moreover, we identify variants in 12 previously unidentified cases of syndromic intellectual disability and demonstrate that these cases and known variants impair H3K23 propionylation. Cardiac anomalies are present in a subset of the cases. H3K23 acylation is also impaired by cancer-derived somatic mutations. Valproate, vorinostat, propionate and butyrate promote H3K23 acylation. These results reveal the dual functionality of BRPF1-KAT6 complexes, shed light on mechanisms underlying related developmental disorders and various cancers, and suggest mutation-based therapy for medical conditions with deficient histone acylation.
赖氨酸乙酰转移酶 6A(KAT6A)及其同源物 KAT6B 与溴结构域和 PH 结构域蛋白 1(BRPF1)形成化学计量比的复合物,以乙酰化组蛋白 H3 赖氨酸 23(H3K23)。我们报告这些复合物也在体外和体内催化 H3K23 丙酰化。免疫荧光显微镜和 ATAC-See 显示这种修饰与活性染色质有关。在小鼠胚胎和成纤维细胞中缺失会消除酰化。此外,我们在 12 个以前未识别的综合征性智力障碍病例中发现了 变异,并证明这些病例和已知的 变异会损害 H3K23 丙酰化。心脏异常存在于一部分病例中。H3K23 酰化也受到癌症衍生的体细胞 突变的影响。丙戊酸、伏立诺他、丙酸盐和丁酸盐促进 H3K23 酰化。这些结果揭示了 BRPF1-KAT6 复合物的双重功能,阐明了相关发育障碍和各种癌症的机制,并为缺乏组蛋白酰化的疾病提供了基于突变的治疗方法。